185 results on '"Gupta AP"'
Search Results
2. Inappropriate Use of Hospital Beds
- Author
-
Gupta, AP, primary
- Published
- 2006
- Full Text
- View/download PDF
3. Medical trainees as agents of change in academic medicine and the health professions
- Author
-
Shoib Sheikh, Gupta Apeksha, Saleem Sheikh Mohd, and Saeed Fahimeh
- Subjects
trainees ,health ,academic promotion ,developing countries ,Medicine - Abstract
Advances and change are inevitable in the health care sector, leading to the promotion and encouragement in medicine and research. Trainees are an excellent resource for evolution because they volunteer at all levels of research and have sufficient clinical experience. Therefore, we will discuss the role of medical trainees as agents of change in academic medicine and health professions overall.
- Published
- 2022
- Full Text
- View/download PDF
4. Utilization of deoiled castor cake for crop production
- Author
-
Gupta, AP, primary, Antil, RS, additional, and Narwal, RP, additional
- Published
- 2004
- Full Text
- View/download PDF
5. QBase Anaesthesia
- Author
-
Gupta, AP, primary
- Published
- 2003
- Full Text
- View/download PDF
6. Influence of soil organic matter on the productivity of pearl millet?-?Wheat cropping system
- Author
-
Gupta, AP, primary, Narwal, RP, additional, and Antil, RS, additional
- Published
- 2003
- Full Text
- View/download PDF
7. Inter-relationships between morphine and codeine in the Indian genetic resources of opium poppy.
- Author
-
Bajpai S, Gupta AP, Gupta MM, and Kumar S
- Abstract
A set of 184 Indian accessions of opium poppy, Papaver somniferum L., were examined for the morphine and codeine contents and yields in the peduncles and capsules. Although wide variation was noted in the codeine content of both capsules and peduncles, the correlation between morphine and codeine was positive and significant. The proportion of codeine to morphine in the peduncle was 1:1.5 and in the capsules 1:5.5. Codeine content of peduncle was not correlated with codeine or morphine contents of capsule and vice-versa. Several of the examined accessions had a codeine content of 0.13 percent in the peduncle or capsule, but no accessions had peduncles and capsules simultaneously rich in codeine. The distribution of codeine and morphine in capsules and peduncles indicated that selection of plants high in codeine and morphine in both capsules and peduncles was probably possible. [ABSTRACT FROM AUTHOR]
- Published
- 2001
- Full Text
- View/download PDF
8. Stool sugar and pH in term breast fed neonates
- Author
-
A. Gupta, Gupta Ap, and R. K. Vyas
- Subjects
medicine.medical_specialty ,business.industry ,Day of life ,Carbohydrates ,Infant, Newborn ,Reducing substances ,Breast milk ,Hydrogen-Ion Concentration ,Term neonates ,Gastroenterology ,Feces ,fluids and secretions ,Breast Feeding ,Reference Values ,Internal medicine ,Pediatrics, Perinatology and Child Health ,Medicine ,Humans ,Female ,business ,Sugar - Abstract
Stool samples from 58, exclusively breast milk fed, term neonates were, examined for first seven days of life, for pH and reducing substances. Stool pH >7 and sugar >0.5% were not recorded in any neonate. On fourth day of life pH stool was 0.1% in 60.35% of the neonates. No detectable sugar was found in 82.7% of neonates, on seventh day of life.
- Published
- 1982
9. Profile of asymmetrical retinopathy of prematurity in twins
- Author
-
Azad Rajvardhan, Chandra Parijat, Patwardhan Sourabh, and Gupta Aparna
- Subjects
Retinopathy of prematurity ,screening retinopathy of prematurity ,twins ,Ophthalmology ,RE1-994 - Abstract
Background: In twin births, both babies have the same gestational age and pre-natal conditions. However, twins may develop a varied retinopathy of prematurity (ROP) course depending on birth weight and other systemic factors. Objective: To study the profile of asymmetric ROP in twins Design: Retrospective study Setting: Tertiary ROP referral eye hospital. Materials and Methods: The profile of 56 pairs of twins with ROP were studied and analyzed for differences in zone or need for treatment, while studying possible causes for the varied outcome. Results: In 45 pairs of twins (80%) the disease progressed identically in both eyes, while in 11 pairs (20%) the ROP showed differences in zone or need for treatment. Four of these pairs were discordant. In 3 of these 4 pairs, the heavier birth weight twin had a more severe ROP course. Conclusions: Twins can present with asymmetric ROP course, and it is therefore essential to examine both twins as per screening protocols.
- Published
- 2010
10. Diagnostic accuracy of cyst fluid amphiregulin in pancreatic cysts
- Author
-
Tun May T, Pai Reetesh K, Kwok Shirley, Dong Aiwen, Gupta Aparna, Visser Brendan C, Norton Jeff A, Poultsides George A, Banerjee Subhas, Van Dam Jacques, Chen Ann M, Friedland Shai, Scott Brennan A, Verma Rahul, Lowe Anson W, and Park Walter G
- Subjects
Diseases of the digestive system. Gastroenterology ,RC799-869 - Abstract
Abstract Background Accurate tests to diagnose adenocarcinoma and high-grade dysplasia among mucinous pancreatic cysts are clinically needed. This study evaluated the diagnostic utility of amphiregulin (AREG) as a pancreatic cyst fluid biomarker to differentiate non-mucinous, benign mucinous, and malignant mucinous cysts. Methods A single-center retrospective study to evaluate AREG levels in pancreatic cyst fluid by ELISA from 33 patients with a histological gold standard was performed. Results Among the cyst fluid samples, the median (IQR) AREG levels for non-mucinous (n = 6), benign mucinous (n = 15), and cancerous cysts (n = 15) were 85 pg/ml (47-168), 63 pg/ml (30-847), and 986 pg/ml (417-3160), respectively. A significant difference between benign mucinous and malignant mucinous cysts was observed (p = 0.025). AREG levels greater than 300 pg/ml possessed a diagnostic accuracy for cancer or high-grade dysplasia of 78% (sensitivity 83%, specificity 73%). Conclusion Cyst fluid AREG levels are significantly higher in cancerous and high-grade dysplastic cysts compared to benign mucinous cysts. Thus AREG exhibits potential clinical utility in the evaluation of pancreatic cysts.
- Published
- 2012
- Full Text
- View/download PDF
11. Book review: Base anaesthesia : 2 MCQs for the final FRCA.
- Author
-
Gupta, AP
- Published
- 2003
- Full Text
- View/download PDF
12. Costunosides A-C: cytotoxic sesquiterpene lactones from the rhizomes of Aucklandia costus Falc.
- Author
-
Bhushan A, Rani D, Lone BA, Tabassum M, Gupta AP, Mondhe DM, Gairola S, Gupta PN, and Gupta P
- Subjects
- Humans, Molecular Structure, Cell Line, Tumor, Drug Screening Assays, Antitumor, Sesquiterpenes, Eudesmane pharmacology, Sesquiterpenes, Eudesmane chemistry, Sesquiterpenes, Eudesmane isolation & purification, A549 Cells, HCT116 Cells, Cholinesterase Inhibitors pharmacology, Cholinesterase Inhibitors chemistry, Magnetic Resonance Spectroscopy, Rhizome chemistry, Lactones chemistry, Lactones pharmacology, Lactones isolation & purification, Sesquiterpenes pharmacology, Sesquiterpenes chemistry, Sesquiterpenes isolation & purification, Antineoplastic Agents, Phytogenic pharmacology, Antineoplastic Agents, Phytogenic chemistry
- Abstract
Three new eudesmane type rare sesquiterpene lactone galactosides, costunosides A-C ( 1-3) were isolated from the rhizomes of Aucklandia costus along with ten known compounds ( 4-13 ). Costunosides A-C ( 1-3) are the first example of naturally eudesmane glycosides containing a β -galactopyranoside moiety. The structure and relative configurations of these compounds were established by comprehensive analysis of MS and, in particular 1D/2D NMR spectroscopic data. The isolated compounds were tested against a panel of human cancer cell lines, where compounds 3, 6 and 7 have shown promising cytotoxic activity against PC-3, HCT-116 and A549 cell lines with IC
50 values in the range of 3.4 µM to 9.3 µM, respectively. Costunosides A-C ( 1-3) were also screened for inhibition assay of acetyl-cholinesterase (AChE), and butyrylcholinesterase (BChE) and found inactive at a concentration of 10 µM.- Published
- 2024
- Full Text
- View/download PDF
13. Optimization of indole acetic acid produced by plant growth promoting fungus, aided by response surface methodology.
- Author
-
Arora P, Tabssum R, Gupta AP, Kumar S, and Gupta S
- Abstract
Indole acetic acid (IAA) is one of the prime communicator playing a chief role in the interaction between host plant and endophytes. IAA produced by the endophytes primarily contributes to plant growth and development. Here, we optimized IAA production by an endophytic fungus Diaporthe terebinthifolli GG3F6 isolated from the asymptomatic rhizome of Glycyrrhiza glabra employing response surface methodology (RSM) and exploring its effect on the host plant biology. The methodology revealed 1.1 fold increases in IAA accumulation. The maximum IAA (121.20 μg/mL) was achieved using tryptophan substrate (1 mg/mL) in Potato dextrose broth (48 g/L) adjusted to pH 12 and incubated at 35 °C for 7 days. The significantly low p-value (p < 0.0001) of the experiment propounded that the model best fits the experimental data, and the independent variables have considerable effects on the production of IAA. Morphologically, the in-vitro grown G. glabra plants showed enhanced root and shoot growth when co-cultivated with the isolated endophytic fungal strain (GG3F6) relative to the control plants. Also, the enhanced accumulation of total phenolic (10.7 %) and flavonoid (10.2 %) in the endophyte treated plants was observed. The optimization of IAA production by an endophytic fungus using (RSM) has not been reported so far. Interestingly, 2.1 fold increase in glycyrrhizin content was recorded in GG3F6 treated in-vitro host plants as compared to the control plants. This suggested a potential use of D. terebinthifolli as a biostimulator for plant and enhanced accumulation of glycyrrhizin. The study highlights the dynamic host-endophyte interaction for exploitation in agricultural and pharmaceutical applications., Competing Interests: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (© 2024 The Authors. Published by Elsevier Ltd.)
- Published
- 2024
- Full Text
- View/download PDF
14. In-vitro antioxidant and anti-inflammatory potential along with p.o. pharmacokinetic profile of key bioactive phytocompounds of Snow Mountain Garlic: a comparative analysis vis-à-vis normal garlic.
- Author
-
Kaur B, Kumar N, Kumari L, Gupta AP, Sharma R, Chopra K, and Saxena S
- Subjects
- Animals, Mice, RAW 264.7 Cells, Tandem Mass Spectrometry methods, Cysteine pharmacology, Chromatography, Liquid methods, Phytochemicals pharmacology, Phytochemicals pharmacokinetics, Oxidative Stress drug effects, Male, Garlic chemistry, Anti-Inflammatory Agents pharmacology, Anti-Inflammatory Agents pharmacokinetics, Antioxidants pharmacology, Antioxidants pharmacokinetics, Plant Extracts pharmacology, Plant Extracts pharmacokinetics, Macrophages drug effects, Macrophages metabolism
- Abstract
Snow mountain garlic (SMG) is a trans-Himalayan medicinal plant used in the traditional medicine system for several ailments, including inflammatory arthritis. Research studies are insufficient to validate its folk medicinal applications. In the present study, the comparative abundance of its key bioactive phytocompounds, viz., S-allyl-L-cysteine (SAC), alliin, and S-methyl-L-cysteine (SMC) against normal garlic were assessed using the LC-MS/MS-MRM method. In addition, the study also explored the antioxidant and anti-inflammatory potency of crude extract of SMG and purified signature phytocompounds (i.e., SMC, SAC, and alliin) in comparison with normal garlic and dexamethasone in LPS-stimulated RAW264.7 macrophage cells. The LC-MS/MS-MRM study revealed significant differences among SMG and normal garlic, viz., alliin 22.8-fold higher in SMG, and SMC could be detected only in SMG. In the bioassays, SMG extract and purified signature phytocompounds significantly downregulated oxidative damage in activated macrophages, boosting endogenous antioxidants' activity. SMG extract-treated macrophages significantly suppressed NF-κB expression and related inflammatory indicators such as cytokines, COX-2, iNOS, and NO. Notably, the observed anti-inflammatory and antioxidant bioactivities of SMG extract were comparable to signature phytocompounds and dexamethasone. In addition, SAC being uniformly found in SMG and normal garlic, its comparative pharmacokinetics was studied to validate the pharmacodynamic superiority of SMG over normal garlic. Significantly higher plasma concentrations (Cmax), half-life (t1/2), and area under curve (AUC) of SAC following SMG extract administration than normal garlic validated the proposed hypothesis. Thus, the abundance of bioactive phytocompounds and their better pharmacokinetics in SMG extract might be underlying its medicinal merits over normal garlic., (© 2024. The Author(s), under exclusive licence to Springer Nature Switzerland AG.)
- Published
- 2024
- Full Text
- View/download PDF
15. Comprehensive Evaluation and Arthroscopic Management of Circumferential Labral Tears Following Traumatic First Time Shoulder Dislocation: A Case Report and Review.
- Author
-
Gupta AP, Kumar P, Bhadani JS, Mukhopadhaya J, Matish M, and Rajnish RK
- Abstract
Introduction: Pan-labral tears, commonly associated with recurrent shoulder dislocations, are a well-documented pathology. However, circumferential pan-labral tears following a first-time shoulder dislocation represent a rare and scarcely reported entity in the literature. Accurate diagnosis requires a comprehensive clinical history, physical examination, and further evaluation, often involving MRI. Even with advanced imaging, the acute nature of the injury can lead to the oversight of pan-labral tears, necessitating arthroscopic assessment for definitive diagnosis. Repairing such extensive glenoid labral tears presents a challenging task, requiring skilled surgeons to utilize accessory portals and percutaneous techniques for optimal visualization and anchor placement trajectory. To the best of our knowledge, this case report represents the first documentation of a pan-labral tear associated with a 1st-time shoulder dislocation., Case Report: A 27-year-old Asian male presented with pain and limited range of motion in the left shoulder following a single episode of anterior shoulder dislocation during cricket. Initial X-rays were unremarkable, but subsequent MRI revealed an anteroinferior labral tear with intact rotator cuffs. Arthroscopic evaluation disclosed a pan-labral tear, prompting meticulous repair under general and locoregional anesthesia. The patient achieved full recovery postoperatively., Conclusion: While pan-labral tears are typically linked to recurrent dislocations, this case underscores their occurrence in a 1st-time traumatic shoulder dislocation without overt clinical signs or fractures. Arthroscopic repair demands careful intraoperative planning to achieve optimal tensioning and alignment of labral and capsular tissues. This report contributes to the limited literature on pan-labral tears associated with initial shoulder dislocations, emphasizing the importance of arthroscopic evaluation for accurate diagnosis and successful repair., Competing Interests: Conflict of Interest: Nil, (Copyright: © Indian Orthopaedic Research Group.)
- Published
- 2024
- Full Text
- View/download PDF
16. Biodiversity of endosymbiont fungi associated with a marine sponge Lamellodysidea herbacea and their potential as antioxidant producers.
- Author
-
Katoch M, Singh G, Bijarnia E, Gupta AP, Azeem M, Rani P, and Kumar J
- Abstract
This study aims to isolate endosymbiontic fungi from the marine sponge Lamellodysidea herbacea and to explore their antioxidant potential. Marine-derived fungi, with their vast biodiversity, are considered a promising source of novel antioxidants which can replace synthetic ones. Marine sponges have previously reported bioactive properties that could ameliorate oxidative stress, particularly their associated fungi, producing high-frequency bioactive molecules (adaptogenic molecules) in response to stressors. 19 endosymbiont fungi associated with marine sponges were isolated, and their extracts were evaluated for their antioxidant capacities. Extract of an endosymbiont fungus, isolate SPG6, identified as Alternaria destruens , through surface electron microscopy (SEM) and ITS gene sequencing, showed broad range antioxidant activities (EC
50 values) (free radical scavenging 32.54 mg L-1 , Hydroxyl radical scavenging activity < 0.078 g L-1 , total reducing power 0.114 g L-1 , Chelating power 0.262 g L-1 , H2 O2 scavenging activity < 0.078 g L-1 , and Superoxide radical scavenging activity > 5.0 g L-1 ). The extract of isolate SPG6 was fractioned and analyzed through GC-MS. Marine sponge-associated endosymbiont fungi are a rich source of antioxidant molecules., Supplementary Information: The online version contains supplementary material available at 10.1007/s13205-024-03972-1., Competing Interests: Conflict of interestThe authors declare no competing interests., (© King Abdulaziz City for Science and Technology 2024. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.)- Published
- 2024
- Full Text
- View/download PDF
17. Outcome of Osteosynthesis of Late-Presenting Proximal Humerus Non-union: A Case Series.
- Author
-
Mukhopadhaya J, Singh NN, Gupta AP, and Bhadani JS
- Abstract
Introduction: It can be challenging to treat proximal humeral non-union (PHN). The challenge gets compounded when they are presented either late or after previous surgery. The challenges are far greater due to small proximal fragments, scalloping of the head, medial bone defect, osteoporosis, soft tissue contractures, and problems related to the previous implants., Material and Methods: In this retro-prospective study (2007-2020), we report on six cases of PHN which were presented to us more than 5 years after the original injury and managed using an intra-medullary autologous fibular strut graft (FSG) along with fixation with a proximal humeral locking plate and cancellous bone grafting. We quantified shoulder function based on constant score and disabilities of the arm, shoulder and hand (DASH) score., Results: The mean age of patients is found to be 54.3 years (range, 22-74 years) with females dominating our study. The mean pre-operative constant score is 26.33 which improved to 71.83 in the post-operative period. The mean DASH score is 77.98 preoperatively, which improved to 19.5 postoperatively. The paired sample t-test compared the difference in mean of the pre-operative and post-operative scores, which shows significant improvement in outcome., Conclusion: Even in very late PHN in poor-quality bone, the additional use of intramedullary strut grafts provides structural support to the fixation and further enhances the ability to withstand the load-start early motion and have a satisfactory functional outcome. Keywords: Non-union, proximal humerus non-union, proximal humerus fracture, proximal humerus internal locking system, locking plate, autogenous fibular strut graft., Competing Interests: Conflict of Interest: Nil, (Copyright: © Indian Orthopaedic Research Group.)
- Published
- 2024
- Full Text
- View/download PDF
18. Endophytic fungal community of Rosa damascena Mill. as a promising source of indigenous biostimulants: Elucidating its spatial distribution, chemical diversity, and ecological functions.
- Author
-
Bashir A, Manzoor MM, Ahmad T, Farooq S, Sultan P, Gupta AP, and Riyaz-Ul-Hassan S
- Subjects
- Ecosystem, Agriculture, Alternaria, Benzyl Alcohol, Endophytes, Mycobiome, Rosa
- Abstract
The role of endophytes in maintaining healthy plant ecosystems and holding promise for agriculture and food security is deeply appreciated. In the current study, we determine the community structure, spatial distribution, chemical diversity, and ecological functions of fungal endophytes of Rosa damascena growing in the North-Western Himalayas. Culture-dependent methods revealed that R. damascena supported a rich endophyte diversity comprising 32 genera and 68 OTUs. The diversity was governed by climate, altitude, and tissue type. Species of Aspergillus, Cladosporium, Penicillium, and Diaporthe were the core endophytes of the host plant consisting of 48.8% of the endophytes collectively. The predominant pathogen of the host was Alternaria spp., especially A. alternata. GC-MS analyses affirmed the production of diverse arrays of volatile organic compounds (VOC) by individual endophytes. Among the primary rose oil components, Diaporthe melonis RDE257, and Periconia verrucosa RDE85 produced phenyl ethyl alcohol (PEA) and benzyl alcohol (BA). The endophytes displayed varied levels of plant growth-promoting, colonization, and anti-pathogenic traits. Between the selected endophytes, P. verrucosa and D. melonis significantly potentiated plant growth and the flavonoids and chlorophyll content in the host. The potential of these two endophytes and their metabolites PEA and BA was confirmed on Nicotiana tabacum. The treatments of the metabolites and individual endophytes enhanced the growth parameters in the model plant significantly. The results imply that P. verrucosa and D. melonis are potential plant growth enhancers and their activity may be partially due to the production of PEA and BA. Thus, R. damascena harbors diverse endophytes with potential applications in disease suppression and host growth promotion. Further investigations at the molecular level are warranted to develop green endophytic agents for sustainable cultivation of R. damascena and biocontrol of leaf spot disease., Competing Interests: Declaration of Competing Interest The authors have no competing interest to report., (Copyright © 2023 Elsevier GmbH. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
19. HPLC-PDA Method for Quantification of Bioactive Compounds in Crude Extract and Fractions of Aucklandia costus Falc. and Cytotoxicity Studies against Cancer Cells.
- Author
-
Bhushan A, Rani D, Tabassum M, Kumar S, Gupta PN, Gairola S, Gupta AP, and Gupta P
- Subjects
- Chromatography, High Pressure Liquid, Plant Extracts pharmacology, Plant Extracts chemistry, Hexanes, Chloroform, Reproducibility of Results, Saussurea chemistry, Neoplasms
- Abstract
Aucklandia costus Falc. (Synonym: Saussurea costus (Falc.) Lipsch.) is a perennial herb of the family Asteraceae. The dried rhizome is an essential herb in the traditional systems of medicine in India, China and Tibet. The important pharmacological activities reported for Aucklandia costus are anticancer, hepatoprotective, antiulcer, antimicrobial, antiparasitic, antioxidant, anti-inflammatory and anti-fatigue activities. The objective of this study was the isolation and quantification of four marker compounds in the crude extract and different fractions of A. costus and the evaluation of the anticancer activity of the crude extract and its different fractions. The four marker compounds isolated from A. costus include dehydrocostus lactone, costunolide, syringin and 5-hydroxymethyl-2-furaldehyde. These four compounds were used as standard compounds for quantification. The chromatographic data showed good resolution and excellent linearity (r
2 ˃ 0.993). The validation parameters, such as inter- and intraday precision (RSD < 1.96%) and analyte recovery (97.52-110.20%; RSD < 2.00%),revealed the high sensitivity and reliability of the developed HPLC method. The compounds dehydrocostus lactone and costunolide were concentrated in the hexane fraction (222.08 and 65.07 µg/mg, respectively) and chloroform fraction (99.02 and 30.21 µg/mg, respectively), while the n -butanol fraction is a rich source of syringin (37.91 µg/mg) and 5-hydroxymethyl-2-furaldehyde (7.94 µg/mg). Further, the SRB assay was performed for the evaluation of anticancer activity using lung, colon, breast and prostate cancer cell lines. The hexane and chloroform fractions show excellent IC50 values of 3.37 ± 0.14 and 7.527 ± 0.18 µg/mL, respectively, against the prostate cancer cell line (PC-3).- Published
- 2023
- Full Text
- View/download PDF
20. An assessment of the physicochemical characteristics and essential oil composition of Mentha longifolia (L.) Huds. exposed to different salt stress conditions.
- Author
-
Singh R, Ahmed S, Luxmi S, Rai G, Gupta AP, Bhanwaria R, and Gandhi SG
- Abstract
Salt stress adversely influences growth, development, and productivity in plants, resulting in a limitation on agriculture production worldwide. Therefore, this study aimed to investigate the effect of four different salts, i.e., NaCl, KCl, MgSO
4 , and CaCl2 , applied at various concentrations of 0, 12.5, 25, 50, and 100 mM on the physico-chemical properties and essential oil composition of M. longifolia . After 45 days of transplantation, the plants were irrigated at different salinities at 4-day intervals for 60 days. The resulting data revealed a significant reduction in plant height, number of branches, biomass, chlorophyll content, and relative water content with rising concentrations of NaCl, KCl, and CaCl2 . However, MgSO4 poses fewer toxic effects than other salts. Proline concentration, electrolyte leakage, and DPPH inhibition (%) increase with increasing salt concentrations. At lower-level salt conditions, we had a higher essential oil yield, and GC-MS analysis reported 36 compounds in which (-)-carvone and D-limonene covered the most area by 22%-50% and 45%-74%, respectively. The expression analyzed by qRT-PCR of synthetic Limonene (LS) and Carvone (ISPD) synthetic genes has synergistic and antagonistic relationships in response to salt treatments. To conclude, it can be said that lower levels of salt enhanced the production of essential oil in M. longifolia , which may provide future benefits commercially and medicinally. In addition to this, salt stress also resulted in the emergence of novel compounds in essential oils, for which future strategies are needed to identify the importance of these compounds in M. longifolia ., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2023 Singh, Ahmed, Luxmi, Rai, Gupta, Bhanwaria and Gandhi.)- Published
- 2023
- Full Text
- View/download PDF
21. Redox-Responsive Hyaluronic Acid-Tacrolimus Conjugate: Synthesis, Characterization, and In Vitro Immunosuppressive Activity.
- Author
-
Singh D, Qasam I, Paudwal G, Kotwal P, Behera C, Kumar A, Gupta AP, Nandi U, Yadav G, Gupta PN, and Shankar R
- Subjects
- Hyaluronic Acid pharmacology, Hyaluronic Acid chemistry, Oxidation-Reduction, Solubility, Tacrolimus pharmacology, Prodrugs pharmacology
- Abstract
A redox-responsive macromolecular prodrug of tacrolimus, HA-ss-Tac, was constructed by conjugation of tacrolimus (TAC, FK506) through its succinate ester to cystamine-modified hyaluronic acid (HA-Cys), and its physicochemical properties and immunosuppressive activity were studied. The synthesized HA-ss-TAC was determined to contain 8% of chemically loaded TAC with significantly enhanced water solubility. The release study showed a sustained release of drug through slow degradation of linker-drug bonds. In vitro inhibition of proliferation of T- and B-lymphocytes was almost comparable to that of TAC, implying that the biologically active compound could be released from the conjugate. The polymeric prodrug lacks obvious cytotoxicity on Raw 264.7 macrophages and significantly suppressed the production of inflammatory cytokines IL-2 and IL-1β by LPS-activated cells. Additionally, the cellular uptake study of the FITC-labeled conjugate confirmed the HA receptor-mediated internalization of the conjugate into targeted cells, thus avoiding systemic side effects. Taken together, the HA-ss-TAC prodrug could be an optimal prodrug for intravenous administration based on this preliminary data and can be expected to have improved therapeutic efficacy.
- Published
- 2023
- Full Text
- View/download PDF
22. Pancreastatin inhibitor PSTi8 balances energy homeostasis by attenuating adipose tissue inflammation in high fat diet fed mice.
- Author
-
Goand UK, Verma S, Gupta AP, Garg R, Dadge S, and Gayen JR
- Subjects
- Mice, Animals, Chromogranin A, Mice, Inbred C57BL, Adipose Tissue metabolism, Inflammation drug therapy, Inflammation metabolism, Obesity drug therapy, Obesity metabolism, Homeostasis, Diet, High-Fat adverse effects, Insulin Resistance
- Abstract
Pancreastatin (PST) is an endogenous bioactive peptide. PST is generated from chromogranin A (Chga) protein which is released by chromaffin and neuroendocrine cells. PST exhibits diabetogenic effect by antagonizing the action of insulin in adipocytes. The level of PST rises during obesity, resulting in persistent low-grade inflammation in adipocytes. Pancreastatin inhibitor 8 (PSTi8), which is developed by modification of PST sequence which antagonizes the action of PST. In this study, we investigated the immunometabolic effect of PSTi8 in the diet-induced obesity (DIO) model in C57BL/6 mice. Here we found PSTi8 decreased the body weight gain, fat mass and increased the lean mass in (DIO) mice. It also showed reduction of adipocyte hypertrophy in eWAT and lipid accumulation in liver of DIO mice. Immunoprofiling of stromal vascular fraction isolated from eWAT of PTSi8 treated mice showed increased anti-inflammatory M2 macrophages, Eosinophil, T-regulatory cells and reduced pro-inflammatory M1 macrophages, CD4 and CD8 T cell population. Apart from this, PSTi8 also improved the mitochondrial function by decreasing reactive oxygen species and increasing mitochondrial membrane potential, NADPH/NADP ratio and citrate synthase activity in eWAT of DIO mice. It also increased the protein expression of pAMPK, pAKT, Arginase -1 and decreased the expression of MHC-II and iNOS in eWAT of DIO mice. In conclusion, PSTi8 exerted its beneficial effect on restoring energy expenditure by reducing adipose tissue inflammation., Competing Interests: Disclosure statements The authors disclose no potential conflicts of interest., (Copyright © 2022 Elsevier Inc. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
23. Molecular dissection of genes and promoters involved in glycyrrhizin biosynthesis revealed phytohormone induced modulation in Glycyrrhiza glabra L.
- Author
-
Goyal P, Manzoor MM, Gupta AP, Pandotra P, and Gupta S
- Subjects
- Glycyrrhizic Acid metabolism, Hormones metabolism, Oxidoreductases genetics, Plant Growth Regulators metabolism, Plant Growth Regulators pharmacology, Promoter Regions, Genetic, Glycyrrhiza genetics, Glycyrrhiza metabolism
- Abstract
The study reports cloning and characterization of complete biosynthetic gene cluster committed to glycyrrhizin biosynthesis along with their corresponding promoter regions from Glycyrrhiza glabra. The identified genes namely, β-amyrin synthase, β-amyrin-11-oxidase, 11-oxo-beta-amyrin 30-oxidase and UDP-dependent glucosyltransferase, were hetrologously expressed in Nicotiana benthamiana for functional validation. The phyto-hormone, naphthalene acetic acid was shown to prompt maximum up regulation (1.3-14.0 folds) of all the genes, followed by gibberellic acid (0.001-10.0 folds) and abscisic acid (0.2-7.7 folds) treatments. The promoter-GUS fusion constructs infiltrated leaves of the identified genes exhibited enhanced promoter activity of β-amyrin synthase (3.9 & 3.0 folds) and 11-oxo-beta-amyrin 30-oxidase (3.6 & 3.2 folds) under the GA
3 and NAA treatments, respectively as compared to their respective untreated controls. The transcriptional control of the three phytohormones studied could be correlated to the cis-responsive elements present in the upstream regions of the individual genes. The study provided an insight into the intricate interaction between hormone-responsive motifs with the corresponding co-expression of the glycyrrhizin biosynthetic pathway genes. The study will help in understanding the phytohormones-mediated regulation of glycyrrhizin biosynthesis and its modulation in the plant., (Copyright © 2022 Elsevier B.V. All rights reserved.)- Published
- 2022
- Full Text
- View/download PDF
24. Correction: Chrysomycins A-C, antileukemic naphthocoumarins from Streptomyces sporoverrucosus .
- Author
-
Jain SK, Pathania AS, Parshad R, Raina C, Ali A, Gupta AP, Kushwaha M, Aravinda S, Bhushan S, Bharate SB, and Vishwakarma RA
- Abstract
[This corrects the article DOI: 10.1039/C3RA42884B.]., (This journal is © The Royal Society of Chemistry.)
- Published
- 2022
- Full Text
- View/download PDF
25. Primary hepatic tuberculosis presenting as fever of unknown origin diagnosed by Positron emission tomography/computed tomography scan (PET/CT).
- Author
-
Puri S, Grover A, Choudhary PN, Singh P, and Gupta AP
- Abstract
Tuberculosis (TB), especially extrapulmonary tuberculosis (EPTB), is an important cause of fever of unknown origin (FUO) in areas endemic to TB. Liver involvement in TB in the absence of miliary TB is rare. A definitive diagnosis of primary hepatic TB can be challenging and relies on the histological and/or bacteriological findings of the liver tissue obtained by biopsy. TB should be considered in the differential diagnosis of space-occupying lesions and abscesses of the liver. In our case of a 52-year-old adult male with FUO, a positron emission tomography/computed tomography (PET/CT) scan was used, due to lack of any potential diagnostic clues, and a focal lesion was identified as a potential biopsy site., Competing Interests: There are no conflicts of interest., (Copyright: © 2022 Journal of Family Medicine and Primary Care.)
- Published
- 2022
- Full Text
- View/download PDF
26. Pancreastatin inhibitor PSTi8 prevents free fatty acid-induced oxidative stress and insulin resistance by modulating JNK pathway: In vitro and in vivo findings.
- Author
-
Garg R, Gupta AP, Katekar R, Verma S, Goand UK, Dadge S, and Gayen JR
- Subjects
- Animals, Chromogranin A metabolism, Hep G2 Cells, Humans, Male, Mice, Chromogranin A antagonists & inhibitors, Fatty Acids metabolism, Insulin Resistance, MAP Kinase Kinase 4 metabolism, Oxidative Stress drug effects, Signal Transduction drug effects
- Abstract
Aim: Free fatty acid-mediated obesity plays a crucial role in the pathogenesis of Type 2 Diabetes. FFA induced JNK activation acts as a central regulator in causing hepatic insulin resistance. Similarly, Pancreastatin, a chromogranin A peptide, serves as a crucial link between FFA-induced insulin resistance. Therefore, in the present work, we sought to test Pancreastatin inhibitor PSTi8 to ameliorate FFA-induced hepatic insulin resistance in in vitro and in vivo models., Material and Methods: To verify our objective, we exposed hepatocytes (HepG2 cells) with palmitate (0.3 mM) or palmitate + PSTi8 (200 nM). Parallelly mice were fed either HFD or HFD + PSTi8 (1 mg/kg). After 21 days animals were scanned for increased fat mass, along with GTT, ITT and PTT experiment to check glucose, and insulin tolerance. Furthermore, ROS generation and hepatic glycogen content was measured in FFA exposed hepatocytes. Gene expression and protein expression studies were further conducted to delineate the action mechanism of PSTi8., Key Findings: PSTi8 exposure decreased ROS accumulation, lipid accumulation, and reduced glycogen content in FFA-induced groups. It also enhances glucose uptake and reduces gluconeogenesis to combat the FFA effect. Furthermore, gene expression studies indicate that PSTi8 treatment reduces NADPH oxidase3 (NOX3) expression and inhibits JNK signaling, a predominant source of ROS-induced insulin resistance., Significance: To summarize, the protective effect of PSTi8 on FFA-induced insulin resistance is mediated via inhibition of JNK signaling, which leads to decreased ROS generation and enhanced insulin sensitivity. Hence PSTi8 could be a therapeutic molecule to prevent western diet-induced insulin resistance., (Copyright © 2021. Published by Elsevier Inc.)
- Published
- 2022
- Full Text
- View/download PDF
27. Pregnane-Oximino-Alkyl-Amino-Ether Compound as a Novel Class of TGR5 Receptor Agonist Exhibiting Antidiabetic and Anti-Dyslipidemic Activities.
- Author
-
Gupta J, Singh DP, Verma PC, Rahuja N, Srivastava R, Ahmad I, Jaiswal N, Kumar H, Gupta AP, Gupta V, Misra A, Kushwaha HN, Singh B, Singh SK, Dwivedi AK, Gayen JR, Sanyal S, Srivastava AK, Pratap R, and Tamrakar AK
- Subjects
- Animals, Blood Glucose drug effects, Cell Line, Cricetinae, Diabetes Mellitus, Experimental metabolism, Dyslipidemias metabolism, Fenofibrate pharmacology, Fenofibrate therapeutic use, Glucose Transporter Type 4 metabolism, Humans, Hypoglycemic Agents chemistry, Hypoglycemic Agents pharmacokinetics, Hypoglycemic Agents therapeutic use, Hypolipidemic Agents chemistry, Hypolipidemic Agents pharmacokinetics, Hypolipidemic Agents therapeutic use, Male, Mice, Muscle, Skeletal drug effects, Pregnanes chemistry, Pregnanes pharmacokinetics, Pregnanes therapeutic use, Rats, Rats, Sprague-Dawley, Receptors, G-Protein-Coupled metabolism, Diabetes Mellitus, Experimental drug therapy, Dyslipidemias drug therapy, Hypoglycemic Agents pharmacology, Hypolipidemic Agents pharmacology, Pregnanes pharmacology, Receptors, G-Protein-Coupled agonists
- Abstract
Introduction: The present study deals with the synthesis of pregnane-oximino-amino-alkyl-ethers and their evaluation for antidiabetic and anti-dyslipidemic activities in validated animal and cell culture models., Methods: The effect on glucose tolerance was measured in sucrose-loaded rats; antidiabetic activity was evaluated in streptozotocin (STZ)-induced diabetic rats and genetically diabetic db/db mice; the anti-dyslipidemic effect was characterized in high-fructose, high-fat diet (HFD)-fed dyslipidemic hamsters. The effect on glucose production and glucose utilization was analyzed in HepG2 liver and L6 skeletal muscle cells, respectively., Results: From the synthesized molecules, pregnane-oximino-amino-alkyl-ether (compound 14b) improved glucose clearance in sucrose-loaded rats and exerted antihyperglycemic activity on STZ-induced diabetic rats. Further evaluation in genetically diabetic db/db mice showed temporal decrease in blood glucose, and improvement in glucose tolerance and lipid parameters, associated with mild improvement in the serum insulin level. Moreover, compound 14b treatment displayed an anti-dyslipidemic effect characterized by significant improvement in altered lipid parameters of the high-fructose, HFD-fed dyslipidemic hamster model. In vitro analysis in the cellular system suggested that compound 14b decreased glucose production in liver cells and stimulated glucose utilization in skeletal muscle cells. These beneficial effects of compound 14b were associated with the activation of the G-protein-coupled bile acid receptor TGR5., Conclusion: Compound 14b exhibits antidiabetic and anti-dyslipidemic activities through activating the TGR5 receptor system and can be developed as a lead for the management of type II diabetes and related metabolic complications., (© 2021 S. Karger AG, Basel.)
- Published
- 2022
- Full Text
- View/download PDF
28. Cocculus hirsutus -Derived Phytopharmaceutical Drug Has Potent Anti-dengue Activity.
- Author
-
Shukla R, Rajpoot RK, Poddar A, Ahuja R, Beesetti H, Shanmugam RK, Chaturvedi S, Nayyar K, Singh D, Singamaneni V, Gupta P, Gupta AP, Gairola S, Kumar P, Bedi YS, Jain T, Vashishta B, Patil R, Madan H, Madan S, Kalra R, Sood R, Vishwakarma RA, Reddy DS, Lal AA, Arora U, and Khanna N
- Abstract
Dengue is a serious public health concern worldwide, with ∼3 billion people at risk of contracting dengue virus (DENV) infections, with some suffering severe consequences of disease and leading to death. Currently, there is no broad use vaccine or drug available for the prevention or treatment of dengue, which leaves only anti-mosquito strategies to combat the dengue menace. The present study is an extension of our earlier study aimed at determining the in vitro and in vivo protective effects of a plant-derived phytopharmaceutical drug for the treatment of dengue. In our previous report, we had identified a methanolic extract of aerial parts of Cissampelos pareira to exhibit in vitro and in vivo anti-dengue activity against all the four DENV serotypes. The dried aerial parts of C. pareira supplied by local vendors were often found to be mixed with aerial parts of another plant of the same Menispermaceae family, Cocculus hirsutus , which shares common homology with C. pareira . In the current study, we have found C. hirsutus to have more potent anti-dengue activity as compared with C. pareira . The stem part of C. hirsutus was found to be more potent (∼25 times) than the aerial part (stem and leaf) irrespective of the extraction solvent used, viz ., denatured spirit, hydro-alcohol (50:50), and aqueous. Moreover, the anti-dengue activity of stem extract in all the solvents was comparable. Hence, an aqueous extract of the stem of C. hirsutus (AQCH) was selected due to greater regulatory compliance. Five chemical markers, viz. , Sinococuline, 20-Hydroxyecdysone, Makisterone-A, Magnoflorine, and Coniferyl alcohol, were identified in fingerprinting analysis. In a test of primary dengue infection in the AG129 mice model, AQCH extract at 25 mg/kg body weight exhibited protection when administered four and three times a day. The AQCH was also protective in the secondary DENV-infected AG129 mice model at 25 mg/kg/dose when administered four and three times a day. Additionally, the AQCH extract reduced serum viremia and small intestinal pathologies, viz ., viral load, pro-inflammatory cytokines, and vascular leakage. Based on these findings, we have undertaken the potential preclinical development of C. hirsutus -based phytopharmaceutical, which could be studied further for its clinical development for treating dengue., Competing Interests: This study received funding from Sun Pharmaceutical Industries Limited, which was provided for the conduct of work to IIIM, Jammu, and ICGEB, New Delhi. The investigators from the funder had the following involvement with the study–(1) Design, conduct, analysis, and interpretation: UA, RKR, RA, HB, RSo, and AAL; (2) preparation and characterization of the drug substance and drug product: KN, TJ, BV, RP, HM, SM, and RK. RKR, RA, HB, KN, TJ, BV, RP, HM, SM, RK, RS, AAL, and UA were employed by company Sun Pharmaceutical Industries Limited. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2021 Shukla, Rajpoot, Poddar, Ahuja, Beesetti, Shanmugam, Chaturvedi, Nayyar, Singh, Singamaneni, Gupta, Gupta, Gairola, Kumar, Bedi, Jain, Vashishta, Patil, Madan, Madan, Kalra, Sood, Vishwakarma, Reddy, Lal, Arora and Khanna.)
- Published
- 2021
- Full Text
- View/download PDF
29. Transcriptome-wide identification of squalene epoxidase genes from Glycyrrhiza glabra L.: expression analysis and heterologous expression of GgSQE1 suggest important role in terpenoid biosynthesis.
- Author
-
Manzoor MM, Goyal P, Pandotra P, Dar MS, Dar MJ, Misra P, Gupta AP, Vishwakarma RA, Ahuja A, Dhar MK, and Gupta S
- Subjects
- Phylogeny, Squalene Monooxygenase genetics, Transcriptome genetics, Glycyrrhiza genetics, Triterpenes
- Abstract
Squalene epoxidase (SQE) is a crucial regulatory enzyme for the biosynthesis of several important classes of compounds including sterols and triterpenoids. The present paper identified and characterised five SQE genes (GgSQE1 to GgSQE5) from Glycyrrhiza glabra through transcriptome data mining and homology-based cloning, for the first time. The phylogenetic analysis implied their functional divergence. The ORF corresponding to one of the five SQEs, namely, GgSQE1, was cloned and studied for its function in a heterologous system, following transient and stable expressions. The transient expression followed by GgSQE1 encoding protein purification suggested approximately 58.0-kDa protein following the predicted molecular mass of the deduced protein. The gene expression profiling based on qRT-PCR indicated its highest expression (6.4-folds) in the 10-month-old roots. Furthermore, ABA (12.4-folds) and GA
3 (2.47) treatments upregulated the expression of GgSQE1 in the shoots after 10 and 12 hours, respectively, which was also reflected in glycyrrhizin accumulation. The inductive effects of ABA and GA3 over GgSQE1 expression were also confirmed through functional analysis of GgSQE1 promoters using GUS fusion construct. Stable constitutive expression of GgSQE1 in Nicotiana tabacum modulated the sterol contents. The study could pave the way for understanding the metabolic flux regulation concerning biosynthesis of related sterols and triterpenoids., (© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH, AT part of Springer Nature.)- Published
- 2021
- Full Text
- View/download PDF
30. In-vitro cytotoxicity in relation to chemotypic diversity in diploid and tetraploid populations of Gentiana kurroo Royle.
- Author
-
Jeelani SM, Singh J, Sharma A, Rather GA, Ali SA, Gupta AP, Singh S, and Lattoo SK
- Subjects
- Antineoplastic Agents pharmacology, Cell Line, Tumor, Cell Survival drug effects, Diploidy, Gentiana cytology, Gentiana growth & development, Humans, India, Iridoid Glucosides chemistry, Medicine, Ayurvedic, Phytochemicals analysis, Plant Components, Aerial chemistry, Plant Components, Aerial cytology, Plant Components, Aerial genetics, Plant Extracts chemistry, Plant Roots chemistry, Plant Roots cytology, Plant Roots genetics, Plants, Medicinal cytology, Pyrones chemistry, Tetraploidy, Chromosomes, Plant genetics, Gentiana chemistry, Gentiana genetics, Plant Extracts genetics, Plant Extracts pharmacology, Plants, Medicinal chemistry, Plants, Medicinal genetics
- Abstract
Ethnopharmacological Relevance: Gentiana kurroo is a multipurpose critically endangered medicinal herb prescribed as medicine in Ayurveda in India and exhibits various pharmacological properties including anti-cancer activity. The species is rich repository of pharmacologically active secondary metabolites together with secoiridoidal glycosides., Aim of the Study: The study aimed to investigate the chemical diversity in different populations/cytotypes prevailing in G. kurroo to identify elite genetic stocks in terms of optimum accumulation/biosynthesis of desired metabolites and having higher in-vitro cytotoxicity potential in relation to chemotypic diversity., Material and Methods: The wild plants of the species were collected from different ranges of altitudes from the Kashmir Himalayas. For cytological evaluation, the standard meiotic analysis was performed. The standard LC-MS/MS technique was employed for phytochemical analysis based on different marker compounds viz. sweroside, swertiamarin, and gentiopicroside. Different tissues such as root-stock, aerial parts, and flowers were used for chemo-profiling. Further, the methanolic extracts of diploid and tetraploid cytotypes were assessed for cytotoxic activity by using MTT assay against four different human cancer cell lines., Results: The quantification of major bioactive compounds based on tissue- and location-specific comparison, as well as in-vitro cytotoxic potential among extant cytotypes, was evaluated. The comprehensive cytomorphological studies of the populations from NW Himalayas revealed the occurrence of different chromosomal races viz. n = 13, 26. The tetraploid cytotype was hitherto unreported. The tissue-specific chemo-profiling revealed relative dominance of different phytoconstituents in root-stock. There was a noticeable increase in the quantity of the analyzed compounds in relation to increasing ploidy status along the increasing altitudes. The MTT assay of methanolic extracts of diploid and tetraploid cytotypes displayed significant cytotoxicity potential in tetraploids. The root-stock extracts of tetraploids were highly active extracts with IC
50 value ranges from 5.65 to 8.53 μg/mL against HCT-116 colon cancer., Conclusion: The chemical evaluation of major bioactive compounds in diverse cytotypes from different plant parts along different altitudes presented an appreciable variability in sweroside, swertiamarin, and gentiopicroside contents. Additionally, the concentrations of these phytoconstituents varied for cytotoxicity potential among different screened cytotypes. This quantitative difference of active bio-constituents was in correspondence with the growth inhibition percentage of different tested cancer cell lines. Thus, the present investigation strongly alludes towards a prognostic approach for the identification of elite cytotypes/chemotypes with significant pharmacological potential., (Copyright © 2021 Elsevier B.V. All rights reserved.)- Published
- 2021
- Full Text
- View/download PDF
31. Effect of Oral Propranolol on Periocular Infantile Capillary Hemangioma: Outcomes Based on Extent of Involvement.
- Author
-
Bejjanki KM, Akhtar K, Gupta AP, and Kaliki S
- Subjects
- Administration, Oral, Female, Humans, Infant, Male, Retrospective Studies, Treatment Outcome, Adrenergic beta-Antagonists therapeutic use, Hemangioma, Capillary drug therapy, Propranolol therapeutic use
- Abstract
Purpose: To evaluate the efficacy of oral propranolol in the treatment of periocular infantile capillary hemangioma (CHI) based on the involvement of embryological facial placodes and their extent of anatomical involvement., Methods: Retrospective study of 27 patients., Results: The mean age at the presentation of periocular CHI was 4 months (median, 3 months; range, <1-14 months). There were 11 (41%) males and 16 (59%) females. Based on embryological facial placodes, the involvement was focal in 16 (59%) cases and segmental in 11 (41%) cases. Based on the anatomical distribution, the lesions were preseptal in 4 (15%), postseptal in 13 (48%), and combined in 10 (37%) cases. The duration of use of oral propranolol was 10 months (median, 10 months; range, 4-16 months). Overall, the mean % resolution of periocular CHI was 78% (median, 90%; range, 20%-100%). The mean percentage resolution of focal lesions was 69% (median, 83%; range, 20%-100%), and segmental lesions were 92% (median, 95%; range, 70%-100%). The mean percentage resolution of preseptal component of lesions was 94% (median, 95%; range, 80%-100%) and postseptal component was 74% (median, 85%; range, 20%-100%) over a mean follow-up period of 16 months (median, 15 months; range, 4-37 months). Four (15%) patients exhibited flare-up of lesion after tapering oral propranolol., Conclusion: Oral propranolol is effective in the treatment of periocular CHI. Segmental and preseptal lesions respond better to the treatment compared to focal and postseptal lesions., Competing Interests: There are no conflicts of interest., (Copyright: © 2021 Middle East African Journal of Ophthalmology.)
- Published
- 2021
- Full Text
- View/download PDF
32. Isolated splenic abscess due to melioidosis in type 1 diabetes mellitus: laboratory diagnosis of Burkholderia pseudomallei in resource-restricted setting.
- Author
-
Gupta AP, Halder R, Chakraborty M, and Chakraborty PP
- Subjects
- Abdominal Pain etiology, Adolescent, Diabetes Mellitus, Type 1 complications, Fever etiology, Humans, Male, Tomography, X-Ray Computed, Abdominal Abscess complications, Burkholderia pseudomallei isolation & purification, Diabetes Mellitus, Type 1 drug therapy, Hypoglycemic Agents therapeutic use, Insulin therapeutic use, Melioidosis complications, Melioidosis diagnosis, Splenic Diseases complications
- Abstract
Diabetes mellitus, type 1 in particular, is a well-recognised risk factor for melioidosis, a disease caused by Burkholderia pseudomallei Melioidosis is endemic in Southeast Asia and in northern Australia and has a variety of clinical presentation, isolated splenic abscess being one of them. B. pseudomallei , however, is an uncommon aetiology of splenic abscess. The diagnosis of melioidosis is often overlooked unless the clinician and the microbiologist are suspicious of the condition. Multiple splenic abscesses and perisplenic collection were noted in CT scan of the abdomen in a patient of type 1 diabetes, presenting with fever for preceding 4 weeks. B. pseudomallei was isolated from the splenic aspirate and the diagnosis was made based on gram stain and routine biochemical tests. He was successfully treated with antibiotics. We postulate that the likely route of infection was inoculation through skin, the integrity of which was compromised by multiple subcutaneous insulin injections., Competing Interests: Competing interests: None declared., (© BMJ Publishing Group Limited 2021. No commercial re-use. See rights and permissions. Published by BMJ.)
- Published
- 2021
- Full Text
- View/download PDF
33. Natural podophyllotoxin analog 4DPG attenuates EMT and colorectal cancer progression via activation of checkpoint kinase 2.
- Author
-
Katoch A, Nayak D, Faheem MM, Kumar A, Sahu PK, Gupta AP, Kumar LD, and Goswami A
- Abstract
Epithelial-mesenchymal transition (EMT) is critical for the metastatic dissemination of cancer cells and contributes to drug resistance. In this study, we observed that epithelial colorectal cancer (CRC) cells transiently exposed to 5-fluorouracil (5-FU) (a chemotherapeutic drug for CRC) as well as 5-FU-resistant cells (5-FU-R) develop EMT characters as evidenced by activation of Vimentin and augmented invasive properties. On the other hand, 4DPG (4'-demethyl-deoxypodophyllotoxin glucoside), a natural podophyllotoxin analog attenuates EMT and invadopodia formation abilities of HCT-116/5-FU-R and SW-620/5-FU-R cells. Treatment with 4DPG restrains Vimentin phosphorylation (Ser38) in 5-FU-R cells, along with downregulation of mesenchymal markers Twist1 and MMP-2 while augmenting the expression of epithelial markers E-cadherin and TIMP-1. Moreover, 4DPG boosts the tumor-suppressor protein, checkpoint kinase 2 (Chk2) via phosphorylation at Thr68 in a dose-dependent manner in 5-FU-R cells. Mechanistically, SiRNA-mediated silencing of Chk2, as well as treatment with Chk2-specific small-molecule inhibitor (PV1019), divulges that 4DPG represses Vimentin activation in a Chk2-dependent manner. Furthermore, immunoprecipitation analysis unveiled that 4DPG prevents complex formation between Vimentin and p53 resulting in the rescue of p53 and its nuclear localization in aggressive 5-FU-R cells. In addition, 4DPG confers suitable pharmacokinetic properties and strongly abrogates tumor growth, polyps formation, and lung metastasis in an orthotopic rat colorectal carcinoma model. In conclusion, our findings demonstrate 4DPG as a targeted antitumor/anti-metastatic pharmacological lead compound to circumvent EMT-associated drug resistance and suggest its clinical benefits for the treatment of aggressive cancers.
- Published
- 2021
- Full Text
- View/download PDF
34. PSTi8 with metformin ameliorates perimenopause induced steatohepatitis associated ER stress by regulating SIRT-1/SREBP-1c axis.
- Author
-
Singh P, Reza MI, Syed AA, Garg R, Husain A, Katekar R, Goand UK, Riyazuddin M, Gupta AP, and Gayen JR
- Abstract
Aims: Hepatic steatosis in women confronting menopause is the manifestation of substantial fructose consumption and forms a positive feedback loop to develop endoplasmic reticulum (ER) stress. Previously pancreastatin inhibitor peptide-8 (PSTi8) and Metformin (Met) combination effectively ameliorated hepatic lipid accumulation in high fructose diet (HFrD) fed diabetic mice models at reduced doses. Moreover, SIRT-1 plays a crucial role in the regulation of SREBP-1c. Hence we hypothesized that Met and PSTi8 in combination (at therapeutic lower doses) could mitigate hepatic steatosis linked ER stress by activating SIRT-1 and precluding SREBP-1c in HFrD fed 4-Vinylcyclohexenediepoxide (HVCD) induced perimenopausal rats., Main Methods: HVCD rats were fed HFrD for 12 weeks, accompanied by 14 days of treatment with Met, PSTi8, and combination. We confirmed model establishment by estrus cycle study, estradiol level, and intraperitoneal glucose tolerance test. Plasma lipid profile and liver function were determined. Also, mRNA and protein expressions were examined. Moreover, distribution of SIRT-1 and SREBP-1c was detected in HepG2 cells by immunofluorescence staining., Key Findings: HVCD group displayed augmented insulin resistance (IR), lipogenesis, and ER stress in the liver. Combination therapy improved the estrus cyclicity, estradiol, and lipid profile of HVCD rats. Met and PSTi8 combination reduced hepatic SREBP-1c and triggered SIRT-1 expression in high fructose-induced insulin-resistant HepG2 cells; consequently, combination therapy attenuated ER stress., Significance: Succinctly, present research promotes impetus concerning the remedial impact of Met with PSTi8 at lower therapeutic doses to ameliorate hepatic IR, steatosis, and associated ER stress by revamping the SIRT-1/SREBP-1c axis in perimenopausal rats., Competing Interests: The authors declare no conflict of interest., (© 2020 The Author(s).)
- Published
- 2020
- Full Text
- View/download PDF
35. Combination of Pancreastatin inhibitor PSTi8 with metformin inhibits Fetuin-A in type 2 diabetic mice.
- Author
-
Singh P, Garg R, Goand UK, Riyazuddin M, Reza MI, Syed AA, Gupta AP, Husain A, and Gayen JR
- Abstract
In the preceding study, we delineated that high-fat diet (HFD) consumption in mice increases the circulatory level of pancreastatin (PST), which additionally enhances the free fatty acid (FFA) concentration in circulation. Consequently, the aggravated FFA activates Fetuin-A, which facilitates hepatic lipid accumulation, insulin resistance (IR), and culminates in type 2 diabetes (T2D). Metformin (Met) is a widely known first-line drug for the treatment of T2D. We previously unveiled PSTi8, an inhibitor of PST, comprising antidiabetic property. Hence, we hypothesized that combination therapy of Met and PSTi8, at reduced therapeutic doses, would mitigate HFD-induced IR by inhibiting hepatic Fetuin-A in mice model of T2D. C57BL/6 mice were fed HFD for 12 weeks, followed by treatment with Met, PSTi8, and its combination for 10 days. Glucose and insulin tolerance tests were conducted. Circulatory levels of PST, Fetuin-A, and lipid markers were determined. Also, the mRNA and protein expression of Fetuin-A was assessed by qPCR, western blotting, and immunofluorescence. Moreover, the energy expenditure was measured by comprehensive laboratory animal monitoring system (CLAMS). Combination therapy displayed improved PST, Fetuin-A, and lipid profile in plasma. We also found reduced hepatic Fetuin-A, which reduced inhibitory phosphorylation of IRS and increased phosphorylation of AKT. Consequently, ameliorated hepatic lipogenesis, gluconeogenesis, and inflammation. Also, combination treatment attenuated Fetuin-A expression, lipid accumulation, and glucose production in palmitate-induced HepG2 cells. Altogether current study promulgates the beneficial effect of combination therapy of Met and PSTi8 (comparable to alone higher therapeutic doses) to ameliorate Fetuin-A activation, hepatic lipid accumulation, insulin resistance, and associated progressive pathophysiological alterations in T2D., (© 2020 The Authors.)
- Published
- 2020
- Full Text
- View/download PDF
36. Perioperative CT angiography assessment of locally advanced distal pancreatic carcinoma to evaluate feasibility of the modified Appleby procedure.
- Author
-
Gupta AP, Kawamoto S, Javed AA, Weiss MJ, Wolfgang CL, He J, Fishman EK, and Vadvala HV
- Subjects
- Adult, Aged, Feasibility Studies, Female, Humans, Male, Middle Aged, Neoadjuvant Therapy methods, Pancreas diagnostic imaging, Pancreas surgery, Pancreatic Neoplasms therapy, Retrospective Studies, Sensitivity and Specificity, Treatment Outcome, Computed Tomography Angiography methods, Pancreatectomy methods, Pancreatic Neoplasms diagnostic imaging, Pancreatic Neoplasms surgery, Perioperative Care methods
- Abstract
Purpose: To study the perioperative CT angiography (CTA) findings of modified Appleby procedure candidates for the surgical feasibility in patients with locally advanced distal pancreatic cancer (LAPC) and to assess CTA performance., Materials and Methods: This retrospective study evaluated CTA of patients with distal LAPC who underwent modified Appleby procedure between March 2004 and October 2017. Preoperative CT scans performed within up to three months prior to the surgery and postoperative scans, at least one of which was within one month of surgery, were reviewed. Data was collected reporting tumor size, relation to vessels, changes from neoadjuvant chemoradiation, modifications to the surgery and complications. The CTA findings were correlated with operative notes and surgical pathology. Statistical analysis was performed using binary classification method to evaluate CTA performance., Results: Consecutive 20 patients underwent modified Appleby procedure in the study period. In 18/20 patients who received neoadjuvant chemoradiation, mean pancreatic mass size significantly reduced from 4.58 + 1.17 cm to 3.55 + 0.84 cm (p = 0.002). The celiac axis (CA) was encased in all, whereas none of the patients had encasement of the superior mesenteric artery (SMA) or involvement of gastroduodenal artery (GDA). The CTA had 88.89% sensitivity, 100% specificity, and 90% accuracy for evaluating the arterial involvement., Conclusion: Distal LAPC patients, in particular those who have significant size reduction after neoadjuvant chemoradiation, with encasement of CA and without encasement of SMA and GDA can undergo a technically successful modified Appleby procedure. CTA offers accurate and valuable perioperative assessment of the surgical candidates., (Copyright © 2020 Elsevier B.V. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
37. Pancreastatin inhibitor PSTi8 protects the obesity associated skeletal muscle insulin resistance in diet induced streptozotocin-treated diabetic mice.
- Author
-
Gupta AP, Garg R, Singh P, Goand UK, Syed AA, Valicherla GR, Riyazuddin M, Mugale MN, and Gayen JR
- Subjects
- Adipose Tissue, White drug effects, Adipose Tissue, White metabolism, Adipose Tissue, White physiopathology, Adiposity drug effects, Animals, Biomarkers blood, Blood Glucose metabolism, Chromogranin A metabolism, Diabetes Mellitus, Experimental chemically induced, Diabetes Mellitus, Experimental metabolism, Diabetes Mellitus, Experimental physiopathology, Diabetes Mellitus, Type 2 chemically induced, Diabetes Mellitus, Type 2 metabolism, Diabetes Mellitus, Type 2 physiopathology, Diet, High-Fat, Energy Metabolism drug effects, GTPase-Activating Proteins metabolism, Glucose Transporter Type 4 metabolism, Humans, Inflammation Mediators metabolism, Macrophages drug effects, Macrophages metabolism, Male, Mice, Inbred C57BL, Muscle, Skeletal metabolism, Muscle, Skeletal physiopathology, Obesity complications, Obesity metabolism, Obesity physiopathology, Proto-Oncogene Proteins c-akt metabolism, Streptozocin, THP-1 Cells, Blood Glucose drug effects, Chromogranin A antagonists & inhibitors, Diabetes Mellitus, Experimental drug therapy, Diabetes Mellitus, Type 2 drug therapy, Hypoglycemic Agents pharmacology, Insulin Resistance, Muscle, Skeletal drug effects, Obesity drug therapy
- Abstract
Pancreastatin (PST), a chromogranin A (CHGA) derived peptide connects obesity with insulin resistance by inducing inflammation. Previously, we have evaluated potential activity of PST inhibitor (PSTi8) in liver and adipose tissue in type 2 diabetic mice model. In this study we further explore the therapeutic effect of PSTi8 on glucose metabolism in skeletal muscle cells/tissue and its effect on energy homeostasis in diet induced diabetic mice model. In in-vitro studies, we found that PSTi8 increases glucose uptake via enhanced GLUT4 translocation in L6 cells. This positive effect of PSTi8 led us to proceed with in-vivo studies in diabetic mice. C57BL/6 mice were fed HFD or HFrD diet for 12 weeks along with single STZ induction at 4th week followed by PSTi8 treatment. We found that HFD and HFrD model showed increased fat mass, caused glucose intolerance and insulin resistance, with accompanying proinflammatory effect on epididymal white adipose tissue (eWAT) together leading to skeletal muscle insulin resistance. Administration of PSTi8 protects from diet induced inflammatory response and enhances glucose tolerance and insulin sensitivity. PSTi8 improves circulating adipokine and lipid parameters, along with switch in macrophage polarisation from M1 to M2 in stromal vascular fraction of adipose tissue. In addition, treatment of PSTi8 also improves energy homeostasis, decreases circulatory non-esterified fatty acids level and inhibits ceramide deposition in muscle tissue. Overall this increased muscle insulin sensitivity is mediated via AKT/AS160/GLUT4 pathway activation. Our results reveal that PSTi8 inhibits the obesity mediated inflammation which enhances glucose disposal in skeletal muscle., (Copyright © 2020 Elsevier B.V. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
38. LC-ESI-MS/MS assay development and validation of a novel antidiabetic peptide PSTi8 in mice plasma using SPE: An application to pharmacokinetics.
- Author
-
Valicherla GR, Riyazuddin M, Shahi S, Gupta AP, Syed AA, Husain A, and Gayen JR
- Subjects
- Animals, Biological Assay instrumentation, Biological Availability, Calibration, Chromatography, Liquid, Drug Stability, Hypoglycemic Agents administration & dosage, Hypoglycemic Agents pharmacology, Injections, Intraperitoneal, Injections, Intravenous, Male, Mice, Mice, Inbred C57BL, Reference Standards, Spectrometry, Mass, Electrospray Ionization, Tandem Mass Spectrometry, Biological Assay methods, Drug Development, Hypoglycemic Agents blood
- Abstract
PSTi8 is a 21 amino acid pancreastatin inhibitory peptide that demonstrated potent antidiabetic activity in insulin resistant rodent models. The goal of the current work is to establish and validate the LC-ESI-MS/MS bioanalytical assay of PSTi8 in mice plasma in order to unveil its pharmacokinetic (PK) behaviour for the first time. The MS detection of PSTi8 and diprotin A (internal standard, IS) was conducted with Q1/Q3 SRM transitions at 607.80 ([M+4 H]
4+ )/771.20 and 342.20/229.10, respectively using positive ESI. Phenomenex Aqua 5μ 125A (250 × 4.6 mm) column was utilized to separate PSTi8 and IS with a mobile phase consists of MeOH-0.1 % formic acid (1:1, v/v) using 0.4 mL/min flow rate. SPE using medium anion exchange cartridge (Oasis MAX) was used for the extraction of analyte and IS from the mice plasma and the extraction recovery was found to be >55 %. PSTi8 displayed good linearity across the 5-1000 ng/mL concentrations range. The intra- and inter- day accuracy was observed between 99.44-110.20 % and 99.66-110.93 %, respectively. The intra- and inter- day precision was observed between 2.61-4.03 % and 2.90-7.16 %, respectively. The intra-day and inter-day accuracy and precision data was within the 100 ± 15 % nominal values recommended by the United States Food and Drug Administration bioanalytical guidance. The LC-MS/MS assay was validated effectively to investigate the PSTi8 plasma concentrations following intravenous and intraperitoneal PK studies in mice. The absolute bioavailability of PSTi8 was 52.74 ± 13.50 %., Competing Interests: Declaration of Competing Interest The authors declare that, there is no conflict of interests., (Copyright © 2019 Elsevier B.V. All rights reserved.)- Published
- 2020
- Full Text
- View/download PDF
39. Pancreastatin inhibitor PSTi8 attenuates hyperinsulinemia induced obesity and inflammation mediated insulin resistance via MAPK/NOX3-JNK pathway.
- Author
-
Gupta AP, Syed AA, Garg R, Goand UK, Singh P, Riyazuddin M, Valicherla GR, Husain A, and Gayen JR
- Subjects
- 3T3-L1 Cells, Animals, Homeostasis drug effects, Inflammation drug therapy, Inflammation etiology, Inflammation pathology, Lipids blood, Lipogenesis drug effects, Male, Mice, Obesity etiology, Obesity metabolism, Obesity pathology, Oxidative Stress drug effects, Signal Transduction drug effects, Chromogranin A antagonists & inhibitors, Hyperinsulinism complications, Insulin Resistance, JNK Mitogen-Activated Protein Kinases metabolism, Mitogen-Activated Protein Kinases metabolism, NADPH Oxidases metabolism, Obesity drug therapy
- Abstract
Pancreastatin (PST), a chromogranin A derived peptide has anti-insulin effects and plays a significant role in obesity-induced insulin resistance. In obesity and type 2 diabetes mellitus, both insulin and PST level are elevated, but it is not clearly understood how anti-insulin effect of PST get regulated in hyperinsulinemic state. Simultaneously we have explored pancreastatin inhibitor PSTi8 against the native PST in the same hyperinsulinemic state. In in-vitro studies, we found that PST treatment increases lipid droplets and reactive oxygen species production in 3T3L1 adipocyte cells and theses effects of PST was found synergistic with chronic-insulin treatment. Treatment of PSTi8 in 3T3L1 adipocytes attenuates PST effect on lipid droplet formation and reactive oxygen species production. We further validated these findings in epididymal white adipose tissue of C57BL/6 mice, implanted with mini-osmotic insulin pump with and without PSTi8 for 4 weeks. We found that chronic hyperinsulinemia enhanced PST levels in circulation which in turn induces expression of various pro-inflammatory cytokines and oxidative stress. In addition, it also stimulated the expression of lipogenic genes, fat mass and body weight gain through the regulation of circulating adiponectin level. The change in PST mediated inflammatory and lipogenic parameters were attenuated by PSTi8 treatment, leading to enhanced insulin sensitivity and improved glucose homeostasis. PSTi8 rescue from PST mediated insulin resistance in adipose via inhibition of MAPK and NOX3-JNK stress signalling pathway which stimulates GLUT4 expression through activation of AKT-AS160 pathway. Thus PSTi8 may be a novel therapeutic agent for the treatment of hyperinsulinemia induced obesity and inflammation mediated insulin resistance., (Copyright © 2019 Elsevier B.V. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF
40. Development and validation of LC-MS/MS method for quantification of novel PP2A - β-catenin signalling inhibitor, S011-2111 in mice plasma: Application to its preclinical pharmacokinetic studies.
- Author
-
Riyazuddin M, Husain A, Valicherla GR, Verma S, Gupta AP, Praveena KS, Singh A, Avula SR, Sashidhara KV, Datta D, and Gayen JR
- Subjects
- Animals, Erythrocytes, Female, Intestinal Absorption, Male, Mice, Mice, Inbred BALB C, Microsomes, Liver metabolism, Rats, Rats, Sprague-Dawley, Spectrometry, Mass, Electrospray Ionization methods, Chromatography, Liquid methods, Enzyme Inhibitors blood, Enzyme Inhibitors chemistry, Enzyme Inhibitors pharmacokinetics, Protein Phosphatase 2 antagonists & inhibitors, Tandem Mass Spectrometry methods, beta Catenin antagonists & inhibitors
- Abstract
S011-2111 is a semicarbazone and chalcone hybrid demonstrating antiproliferative tumor cell-selective effects along with unique antimetastatic potential by mitigating PP2A-β-catenin signalling pathway. The present study envisaged to explore the in vitro and in vivo pharmacokinetics of S011-2111. A sensitive and selective liquid chromatography-tandem mass spectrometry bioanalytical method was developed and validated to determine S011-2111. It has high permeability across intestinal membrane as observed in in situ single-pass intestinal perfusion study. It has high plasma protein binding and poor aqueous solubility. It was rapidly partitioning into plasma of blood, where it was moderately stable. In mice liver microsomal stability study, S011-2111 was stable against cytochrome P450 enzymes but undergoes rapid glucuronidation with intrinsic clearance of 148.6 ± 48.3 µL/min/mg. Following 100 mg/kg oral dosing of S011-2111, the compound was detectable in the plasma samples up to 24 h with a maximum plasma concentration of 45 ± 16.5 ng/mL at 2.4 ± 0.1 h and absolute bioavailability of 1.68%. Knowledge from this research will assist in further development of S011-2111 as an anti-cancer agent., (Copyright © 2019 Elsevier B.V. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF
41. Pancreastatin inhibitor, PSTi8 ameliorates metabolic health by modulating AKT/GSK-3β and PKCλ/ζ/SREBP1c pathways in high fat diet induced insulin resistance in peri-/post-menopausal rats.
- Author
-
Valicherla GR, Gupta AP, Hossain Z, Riyazuddin M, Syed AA, Husain A, Lahiri S, Dave KM, and Gayen JR
- Subjects
- Animals, Chromogranin A metabolism, Female, Humans, Rats, Chromogranin A antagonists & inhibitors, Dietary Fats pharmacology, Glycogen Synthase Kinase 3 beta metabolism, Insulin Resistance, Isoenzymes metabolism, Molecular Chaperones metabolism, Peptides pharmacology, Postmenopause metabolism, Protein Kinase C metabolism, Proto-Oncogene Proteins c-akt metabolism, Sterol Regulatory Element Binding Protein 1 metabolism
- Abstract
Increase in the prevalence of insulin resistance (IR) in peri-/post-menopause women is mainly due to hormone deficiency and lifestyle. PSTi8 (PEGKGEQEHSQQKEEEEEMAV-amide) is a pancreastatin inhibitor peptide which showed potent antidiabetic activity in genetic and lifestyle induced type 2 diabetic mice. In the present work, we have investigated the antidiabetic activity of PSTi8 in rat models of peri-/post-menopausal IR. 4-vinylcyclohexenediepoxide treated and ovariectomized rats were fed with high fat diet for 12 weeks to develop the peri-/post-menopausal IR. PSTi8 peptide was administered after the development of peri-/post-menopausal IR rats. PSTi8 (1 mg/kg, i.p) improved the glucose homeostasis which is characterized by elevated glycogenesis, enhanced glycolysis and reduced gluconeogenesis. PSTi8 suppressed palmitate- and PST- induced IR in HepG2 cells. PSTi8 treatment enhanced energy expenditure in peri-/post-menopausal IR rats. PSTi8 treatment increased insulin sensitivity in peri-/post-menopausal IR rats, may be mediated by modulating IRS1-2-phosphatidylinositol-3-kinase-AKT-GSK3β and IRS1-2-phosphatidylinositol-3-kinase-PKCλ/ζ-SREBP1c signaling pathways in the liver. PSTi8 can act as a potential therapeutic peptide for the treatment of peri-/post-menopausal IR., (Copyright © 2019 Elsevier Inc. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF
42. Preclinical development of gastro-protective botanical candidate from Woodfordia fruticosa (Linn.) Kurz: Chemical standardization, efficacy, pharmacokinetics and safety pharmacology.
- Author
-
Khan IA, Singh A, Mindala DP, Meena S, Vij B, Yadav AK, Roy S, Nandi U, Katare AK, Jaglan S, Singh D, Gupta AP, Gupta P, Singh S, Tikko MK, Singh G, and Vishwakarma RA
- Subjects
- Animals, Anti-Ulcer Agents pharmacokinetics, Anti-Ulcer Agents toxicity, Ethanol, Female, Flowers, Helicobacter pylori drug effects, Hydrochloric Acid, Male, Mice, Phytotherapy, Plant Extracts pharmacokinetics, Plant Extracts toxicity, Rats, Wistar, Stomach Ulcer chemically induced, Toxicity Tests, Anti-Ulcer Agents therapeutic use, Plant Extracts therapeutic use, Stomach Ulcer drug therapy, Woodfordia
- Abstract
Ethnopharmacological Relevance: Woodfordia fruticosa is traditionally used in the Ayurvedic system of medicine for the treatment of diarrhoea, poisoning, menstrual disorders, ulcers and fertility. In the present study, we report a standardized extract preparation through modern scientific approach for anti-ulcer activity., Materials and Methods: The hydro-alcoholic extract of flowers of W. fruticosa was standardized using four chemical markers. The standardized extract was coded as ICB014. HPLC method was developed for identification and quantification of Gallic Acid, Oenothein-C, Quercetin and Kaempferol. Based on the prior published H
+ , K+ -ATPase activity and Anti-bacterial activity against Helicobacter pylori of ICB014, was evaluated for its in-vivo efficacy in gastric ulcers models in rats followed by regulatory safety studies., Results: The extract demonstrated efficacy at 31.25-62.5 mg/kg in gastric ulcer models. The extract was safe by oral route up to 2000 mg/kg in a single dose and NOAEL of 800 mg/kg in 28 days repeat study. Bioequivalent capsule formulation was prepared., Conclusions: The extract showed anti-ulcer potential and is ready for clinical evaluation., (Copyright © 2019 Elsevier B.V. All rights reserved.)- Published
- 2019
- Full Text
- View/download PDF
43. Fructose-induced AGEs-RAGE signaling in skeletal muscle contributes to impairment of glucose homeostasis.
- Author
-
Rai AK, Jaiswal N, Maurya CK, Sharma A, Ahmad I, Ahmad S, Gupta AP, Gayen JR, and Tamrakar AK
- Subjects
- Animals, Cells, Cultured, Cytokines blood, Energy Metabolism drug effects, Glucose Intolerance, Homeostasis drug effects, Inflammation etiology, Lipid Metabolism drug effects, Male, Muscle Fibers, Skeletal drug effects, Muscle Fibers, Skeletal metabolism, Muscle, Skeletal metabolism, Rats, Sprague-Dawley, Signal Transduction drug effects, Fructose adverse effects, Glucose metabolism, Glycation End Products, Advanced metabolism, Muscle, Skeletal drug effects, Receptor for Advanced Glycation End Products metabolism
- Abstract
Increased fructose intake has been linked to the development of dyslipidemia, obesity and impaired glucose tolerance. Due to its specific metabolic fate, fructose impairs normal lipid and carbohydrate metabolism and facilitates the non-enzymatic glycation reaction leading to enhanced accumulation of advanced glycation end products (AGEs). However, the formation of fructose-AGEs under in vivo setup and its tissue specific accumulation is less explored. Here, we investigated the impact of high fructose on AGEs accumulation in skeletal muscle and its causal role in impaired glucose homeostasis. In L6 rat skeletal muscle cells, chronic exposure to fructose induced AGEs accumulation and the cellular level of the receptor for AGEs (RAGE) and the effect was prevented by pharmacological inhibition of glycation. Under in vivo settings, Sprague Dawley rats exposed to 20% fructose in drinking water for 16 weeks, displayed increased fasting glycemia, impaired glucose tolerance, decreased skeletal muscle Akt (Ser-473) phosphorylation, and enhanced triglyceride levels in serum, liver and gastrocnemius muscle. We also observed a high level of AGEs in serum and gastrocnemius muscle of fructose-supplemented animals, associated with methylglyoxal accumulation and up regulated expression of RAGE in gastrocnemius muscle. Treatment with aminoguanidine inhibited fructose-induced AGEs accumulation and normalized the expression of RAGE and Dolichyl-Diphosphooligosaccharide-Protein Glycosyltransferase (DDOST) in gastrocnemius muscle. Inhibition of AGEs-RAGE axis counteracted fructose-mediated glucose intolerance without affecting energy metabolism. These data reveal diet-derived AGEs accumulation in skeletal muscle and the implication of tissue specific AGEs in metabolic derangement, that may open new perspectives in pathogenic mechanisms and management of metabolic diseases., (Copyright © 2019 Elsevier Inc. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF
44. Indolylkojyl methane analogue IKM5 potentially inhibits invasion of breast cancer cells via attenuation of GRP78.
- Author
-
Nayak D, Katoch A, Sharma D, Faheem MM, Chakraborty S, Sahu PK, Chikan NA, Amin H, Gupta AP, Gandhi SG, Mukherjee D, and Goswami A
- Subjects
- Animals, Antineoplastic Agents chemistry, Antineoplastic Agents pharmacokinetics, Cell Line, Tumor, Cell Movement drug effects, Cell Proliferation drug effects, Cell Survival drug effects, Disease Models, Animal, Doxorubicin pharmacology, Endoplasmic Reticulum Chaperone BiP, Epithelial-Mesenchymal Transition drug effects, Epithelial-Mesenchymal Transition genetics, Female, Heat-Shock Proteins chemistry, Heat-Shock Proteins metabolism, Humans, Matrix Metalloproteinases, Methane analogs & derivatives, Methane chemistry, Methane pharmacokinetics, Mice, Models, Biological, Models, Molecular, Molecular Conformation, Molecular Structure, Protein Transport, Structure-Activity Relationship, Xenograft Model Antitumor Assays, Antineoplastic Agents pharmacology, Heat-Shock Proteins genetics, Methane pharmacology
- Abstract
Purpose: More than 90% of the breast cancer deaths occur due to the metastasis of the cancer cells to secondary organ sites. Increased Glucose-regulated protein 78 (GRP78) expression is critical for epithelial-mesenchymal transition (EMT) and invasion in breast cancer resulting in poor patient survival outcomes. Therefore, there is an urgent need of potential inhibitors of GRP78 for the abrogation of invasion and metastasis in breast cancer., Methods: We investigated the effect of IKM5 (2-(1-(1H-indol-3-yl)octyl)-3-hydroxy-6-(hydroxymethyl)-4H-pyran-4-one) (a novel Indolylkojyl methane analogue) on invasion abilities of human breast cancer cells employing invadopodia formation, Matrigel invasion assays, and mouse models for metastasis. The mechanism underlying the anti-invasive effect of IKM5 was examined through molecular docking, immunoblotting, immunocytochemistry, co-immunoprecipitation analysis, siRNA silencing, and sub-cellular fractionation studies., Results: Treatment with IKM5 at its sub-toxic concentration (200 nM) suppressed invasion and invadopodia formation, and growth factor-induced cell scattering of aggressive human breast cancer MDA-MB-231, MDA-MB-468, and MCF7 cells. IKM5 spontaneously binds to GRP78 (Ki = 1.35 µM) and downregulates its expression along with the EMT markers MMP-2, Twist1, and Vimentin. Furthermore, IKM5 amplified the expression and nuclear translocation of tumor suppressor Par-4 to control NF-kB-mediated pro-EMT activities. Interestingly, IKM5 disrupts the interaction between GRP78 and TIMP-1 by inhibiting GRP78 in a Par-4-dependent manner. Moreover, IKM5 inhibited tumor growth and lung metastasis at a safe dose of 30 mg/kg/body weight., Conclusion: Our study warrants IKM5, a potential anticancer agent that can abrogate invasion and metastasis, suggesting its clinical development for the treatment of patients with advanced breast cancer.
- Published
- 2019
- Full Text
- View/download PDF
45. Pancreastatin inhibitor activates AMPK pathway via GRP78 and ameliorates dexamethasone induced fatty liver disease in C57BL/6 mice.
- Author
-
Gupta AP, Singh P, Garg R, Valicherla GR, Riyazuddin M, Syed AA, Hossain Z, and Gayen JR
- Subjects
- Adenosine Triphosphate metabolism, Adipokines metabolism, Adiposity drug effects, Animals, Chromogranin A metabolism, Dexamethasone, Endoplasmic Reticulum Chaperone BiP, Energy Metabolism, Fatty Liver blood, Glucose metabolism, Hep G2 Cells, Homeostasis drug effects, Humans, Insulin blood, Insulin Resistance, Lipid Metabolism drug effects, Liver metabolism, Liver pathology, Male, Mice, Inbred C57BL, Tissue Distribution drug effects, AMP-Activated Protein Kinases metabolism, Chromogranin A antagonists & inhibitors, Fatty Liver enzymology, Fatty Liver pathology, Heat-Shock Proteins metabolism, Signal Transduction
- Abstract
Aims: To investigate the role of pancreastatin inhibitor (PSTi8) in lipid homeostasis and insulin sensitivity in dexamethasone induced fatty liver disease associated type 2 diabetes., Main Methods: Glucose releases assay, lipid O staining and ATP/AMP ratio were performed in HepG2 cells. Twenty four mice were randomly divided into 4 groups: Control group (saline), DEX (1 mg/kg, im) for 17 days, DEX+PSTi8 (acute 5 mg/kg and chronic 2 mg/kg, ip) for 10 days. The glucose, insulin and pyruvate tolerance tests (GTT, ITT and PTT), biochemical parameters and Oxymax-CLAMS were performed. Further to elucidate the action mechanisms of PSTi8, we performed genes expression and western blotting of biological samples., Key Findings: We found that PSTi8 suppresses hepatic glucose release, lipid deposition, oxidative stress induced by DEX, stimulates the cellular energy level in hepatocytes and enhances GRP78 activity. It reduces lipogensis and enhances fatty acid oxidation to improve insulin sensitivity and glucose tolerance in DEX induced diabetic mice. The above cellular effects are the result of activated AMPK signalling pathway in liver, which increases Srebp1c and ACC phosphorylation. The increased ACC phosphorylation suppresses protein kinase C activity and enhances insulin sensitivity. The increased expression of UCP3 in liver elicits fatty acid oxidation and energy expenditure, which suppress oxidative stress., Significance: Thus the activation of AMPK signalling through GRP78, improves lipid homeostasis, enhances insulin sensitivity via inhibition of PKC activity. PSTi8 suppresses inflammation associated with incomplete fatty acid oxidation. Hence, PSTi8 may be a potential therapeutic agent to treat glucocorticoid-induced fatty liver associated type 2 diabetes., (Copyright © 2019 The Authors. Published by Elsevier Masson SAS.. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF
46. Role of brown adipose tissue in modulating adipose tissue inflammation and insulin resistance in high-fat diet fed mice.
- Author
-
Shankar K, Kumar D, Gupta S, Varshney S, Rajan S, Srivastava A, Gupta A, Gupta AP, Vishwakarma AL, Gayen JR, and Gaikwad AN
- Subjects
- Adipose Tissue, Brown metabolism, Adipose Tissue, Brown pathology, Animals, Biomarkers metabolism, Energy Metabolism, Gene Expression Regulation, Inflammation pathology, Male, Mice, Mice, Inbred C57BL, Obesity metabolism, Obesity pathology, Adipose Tissue, Brown transplantation, Diet, High-Fat adverse effects, Insulin Resistance
- Abstract
Obesity results in the chronic activation of innate immune system and subsequently sets in diabetes. Aim of the study was to investigate the immunometabolic role of brown adipose tissue (BAT) in the obesity. We performed both BAT transplantation as well as extirpation experiments in the mouse model of high-fat diet (HFD)-induced obesity. We carried out immune cell profiling in the stromal vascular fraction (SVF) isolated from epididymal white adipose tissue (eWAT). BAT transplantation reversed HFD-induced increase in body weight gain and insulin resistance without altering diet intake. Importantly, BAT transplantation attenuated the obesity-associated adipose tissue inflammation in terms of decreased pro-inflammatory M1-macrophages, cytotoxic CD8a T-cells and restored anti-inflammatory regulatory T-cells (Tregs) in the eWAT. BAT transplantation also improved endogenous BAT activity by elevating protein expression of browning markers (UCP-1, PRDM16 and PGC1α) in it. In addition, BAT transplantation promoted the eWAT expression of various genes involved in fatty acid oxidation (such as Elvol3 and Tfam,). In contrast, extirpation of the interscapular BAT exacerbated HFD-induced obesity, insulin resistance and adipose tissue inflammation (by increasing M1 macrophages, CD8a T-cell and decreasing Tregs in eWAT). Taken together, our results suggested an important role of BAT in combating obesity-associated metabolic complications. These results open a novel therapeutic option to target obesity and related metabolic disorders like type 2 diabetes., (Copyright © 2019 Elsevier B.V. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF
47. Enhanced potential of biomimetic, silver nanoparticles functionalized Antheraea mylitta (tasar) silk fibroin nanofibrous mats for skin tissue engineering.
- Author
-
Srivastava CM, Purwar R, and Gupta AP
- Subjects
- Algorithms, Animals, Chemical Phenomena, Ionic Liquids chemistry, Models, Theoretical, Molecular Weight, Porosity, Spectrum Analysis, Surface Properties, Biomimetics, Fibroins chemistry, Metal Nanoparticles chemistry, Metal Nanoparticles ultrastructure, Moths chemistry, Silver chemistry, Skin, Tissue Engineering
- Abstract
In the present study, we have successfully prepared tasar fibroin nanofibrous mats using 1‑butyl‑3‑methylimidazolium acetate for skin tissue engineering. The prepared tasar nanofibrous mat was further coated by silver nanoparticles (AgNPs) in situ using dandelion (Tridax procumbens) leaf extract. The kinetic of silver nanoparticles formation was studied by UV-VIS spectrophotometer. The prepared silver nanoparticles were further confirmed by XRD and TEM. The coating of tasar nanofibrous mat with silver nanoparticles was confirmed by EDX and EDX mapping techniques. The physical, mechanical, antimicrobial and biological properties of these silver nanoparticles coated tasar nanofibrous mat were determined in order to check its suitability for skin tissue engineering and wound dressing applications., (Copyright © 2018. Published by Elsevier B.V.)
- Published
- 2019
- Full Text
- View/download PDF
48. Rosiglitazone up-regulates glial fibrillary acidic protein via HB-EGF secreted from astrocytes and neurons through PPARγ pathway and reduces apoptosis in high-fat diet-fed mice.
- Author
-
Kushwaha R, Mishra J, Gupta AP, Gupta K, Vishwakarma J, Chattopadhyay N, Gayen JR, Kamthan M, and Bandyopadhyay S
- Subjects
- Animals, Apoptosis drug effects, Astrocytes metabolism, Brain drug effects, Brain metabolism, Diabetes Mellitus, Experimental metabolism, Diabetes Mellitus, Type 2 metabolism, Diet, High-Fat, Glial Fibrillary Acidic Protein biosynthesis, Heparin-binding EGF-like Growth Factor biosynthesis, Hypoglycemic Agents adverse effects, Mice, Neurons metabolism, PPAR gamma drug effects, PPAR gamma metabolism, Up-Regulation, Astrocytes drug effects, Hypoglycemic Agents pharmacology, Neurons drug effects, Rosiglitazone pharmacology, Signal Transduction drug effects
- Abstract
The anti-diabetic drug and peroxisome proliferator-activated receptor-gamma (PPARγ) agonist, rosiglitazone, alters astrocyte activation; however, its mechanism remains less-known. We hypothesized participation of epidermal growth factor receptor (EGFR), known to control astrocyte reactivity. We first detected that rosiglitazone promoted glial fibrillary acidic protein (GFAP) expression in primary astrocytes as well as the mouse cerebral cortex, associated with increased EGFR activation. Screening for EGFR ligands revealed a rosiglitazone-mediated increase of heparin-binding epidermal growth factor (HB-EGF) in astrocytes, resulting in HB-EGF release into culture medium and mouse cerebrospinal fluid too. Treatment with HB-EGF-siRNA and EGFR inhibitors showed that the rosiglitazone-induced HB-EGF and p-EFGR were interdependent, which participated in GFAP increase. Interestingly, we observed that rosiglitazone could induce cellular and secreted-HB-EGF in neurons also, contributing toward the activated EGFR-induced GFAP in astrocytes. Probing whether these effects of rosiglitazone were PPARγ-linked, revealed potential PPARγ-responsive elements within HB-EGF gene. Moreover, gel-shift, site-directed mutagenesis, chromatin-immunoprecipitation and luciferase-reporter assays demonstrated a PPARγ-dependent HB-EGF transactivation. Subsequently, we examined effects of rosiglitazone in a high-fat diet-fed diabetes mouse model, and supporting observations in the normal cortical cells, identified a rosiglitazone-induced GFAP, astrocyte and neuronal HB-EGF and secreted-HB-EGF in the cerebral cortex of diabetic mice. Moreover, assessing relevance of increased HB-EGF and GFAP revealed an anti-apoptotic role of rosiglitazone in the cerebral cortex, supported by a GFAP-siRNA as well as HB-EGF-siRNA-mediated increase in cleaved-caspase 3 and 9 levels in the rosiglitazone-treated astrocyte-neuron coculture. Overall, our study indicates that rosiglitazone may protect the brain, via a PPARγ-dependent HB-EGF/EGFR signaling and increased GFAP., (© 2018 International Society for Neurochemistry.)
- Published
- 2019
- Full Text
- View/download PDF
49. Cutaneous Melanoma, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology.
- Author
-
Coit DG, Thompson JA, Albertini MR, Barker C, Carson WE, Contreras C, Daniels GA, DiMaio D, Fields RC, Fleming MD, Freeman M, Galan A, Gastman B, Guild V, Johnson D, Joseph RW, Lange JR, Nath S, Olszanski AJ, Ott P, Gupta AP, Ross MI, Salama AK, Skitzki J, Sosman J, Swetter SM, Tanabe KK, Wuthrick E, McMillian NR, and Engh AM
- Subjects
- Humans, Melanoma, Cutaneous Malignant, Medical Oncology standards, Melanoma diagnosis, Skin Neoplasms diagnosis
- Abstract
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Cutaneous melanoma have been significantly revised over the past few years in response to emerging data on immune checkpoint inhibitor therapies and BRAF-targeted therapy. This article summarizes the data and rationale supporting extensive changes to the recommendations for systemic therapy as adjuvant treatment of resected disease and as treatment of unresectable or distant metastatic disease.
- Published
- 2019
- Full Text
- View/download PDF
50. Elucidation of pharmacokinetics of novel DNA ligase I inhibitor, S012-1332 in rats: Integration of in vitro and in vivo findings.
- Author
-
Riyazuddin M, Valicherla GR, Husain A, Hussain MK, Shukla M, Katekar R, Gupta AP, Singh P, Banerjee D, Hajela K, and Gayen JR
- Subjects
- Administration, Oral, Animals, Antineoplastic Agents administration & dosage, Antineoplastic Agents blood, Biological Availability, Chromatography, Liquid, DNA Ligase ATP metabolism, Drug Stability, Enzyme Inhibitors administration & dosage, Enzyme Inhibitors blood, Inactivation, Metabolic, Intestinal Absorption, Intestinal Mucosa metabolism, Male, Microsomes, Liver metabolism, Permeability, Protein Binding, Rats, Sprague-Dawley, Reproducibility of Results, Solubility, Spectrometry, Mass, Electrospray Ionization, Tandem Mass Spectrometry, Antineoplastic Agents pharmacokinetics, DNA Ligase ATP antagonists & inhibitors, Enzyme Inhibitors pharmacokinetics
- Abstract
S012-1332 is the first DNA ligase I inhibitor that demonstrated in vivo anti-breast cancer activity. The present study aimed to assess the in vivo pharmacokinetics of S012-1332 in rats and interpret them with in vitro findings. A sensitive and selective liquid chromatography-tandem mass spectrometry bioanalytical method was developed and validated to determine S012-1332. Following oral administration, the absolute bioavailability was 7.04%. The absorption was prolonged which can be explained by low solubility in simulated gastric fluid and several folds higher solubility in simulated intestinal fluid. The effective permeability across the intestinal membrane in in situ single pass perfusion study for S012-1332 was 5.58 ± 1.83 * 10
-5 cm/sec compared to 5.99 ± 0.65 * 10-5 cm/sec for carbamazepine, with no significant difference, indicating S012-1332 has high permeability. It was rapidly partitioning into plasma in blood, where it was stable. Plasma protein binding was moderate which may have attributed to the rapid distribution out of the vascular compartment. The pharmacokinetics of S012-1332 was characterized by extensive clearance as seen with rat liver and intestinal microsomes. In vitro results elucidate the in vivo pharmacokinetic data. These findings provide crucial information for further development of S012-1332 as anti-breast cancer agent., (Copyright © 2018 Elsevier B.V. All rights reserved.)- Published
- 2019
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.